DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
10.1186/s12943-021-01437-0
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/228996 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| Language: | English |
| id |
sg-nus-scholar.10635-228996 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-2289962023-10-31T20:38:57Z DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes Kizhakeyil, Atish Zaini, Nurmahirah Binte Mohammed Poh, Zhi Sheng Wong, Brandon Han Siang Loh, Xinpeng Ng, Aik Seng Low, Zun Siong Prasannan, Praseetha Gong, Chun Tan, Michelle Guet Khim Nagarajan, Chandramouli Huang, Dachuan Lu, Pang Wan Lim, Jing Quan Barrans, Sharon Ong, Choon Kiat Lim, Soon Thye Chng, Wee Joo Follows, George Hodson, Daniel J Du, Ming Qing Goh, Yeow Tee Tan, Suat Hoon Grigoropoulos, Nicholas Francis Verma, Navin Kumar DEAN'S OFFICE (MEDICINE) Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Oncology DDX3X mutation Hematolymphoid malignancy Prognosis Tumour metastasis Drug resistance CYCLIN D1 EXPRESSION 10.1186/s12943-021-01437-0 MOLECULAR CANCER 20 1 2022-07-21T05:05:03Z 2022-07-21T05:05:03Z 2021-10-16 2022-07-17T12:05:34Z Article Kizhakeyil, Atish, Zaini, Nurmahirah Binte Mohammed, Poh, Zhi Sheng, Wong, Brandon Han Siang, Loh, Xinpeng, Ng, Aik Seng, Low, Zun Siong, Prasannan, Praseetha, Gong, Chun, Tan, Michelle Guet Khim, Nagarajan, Chandramouli, Huang, Dachuan, Lu, Pang Wan, Lim, Jing Quan, Barrans, Sharon, Ong, Choon Kiat, Lim, Soon Thye, Chng, Wee Joo, Follows, George, Hodson, Daniel J, Du, Ming Qing, Goh, Yeow Tee, Tan, Suat Hoon, Grigoropoulos, Nicholas Francis, Verma, Navin Kumar (2021-10-16). DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes. MOLECULAR CANCER 20 (1). ScholarBank@NUS Repository. https://doi.org/10.1186/s12943-021-01437-0 14764598 https://scholarbank.nus.edu.sg/handle/10635/228996 en BMC Elements |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| language |
English |
| topic |
Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Oncology DDX3X mutation Hematolymphoid malignancy Prognosis Tumour metastasis Drug resistance CYCLIN D1 EXPRESSION |
| spellingShingle |
Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Oncology DDX3X mutation Hematolymphoid malignancy Prognosis Tumour metastasis Drug resistance CYCLIN D1 EXPRESSION Kizhakeyil, Atish Zaini, Nurmahirah Binte Mohammed Poh, Zhi Sheng Wong, Brandon Han Siang Loh, Xinpeng Ng, Aik Seng Low, Zun Siong Prasannan, Praseetha Gong, Chun Tan, Michelle Guet Khim Nagarajan, Chandramouli Huang, Dachuan Lu, Pang Wan Lim, Jing Quan Barrans, Sharon Ong, Choon Kiat Lim, Soon Thye Chng, Wee Joo Follows, George Hodson, Daniel J Du, Ming Qing Goh, Yeow Tee Tan, Suat Hoon Grigoropoulos, Nicholas Francis Verma, Navin Kumar DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| description |
10.1186/s12943-021-01437-0 |
| author2 |
DEAN'S OFFICE (MEDICINE) |
| author_facet |
DEAN'S OFFICE (MEDICINE) Kizhakeyil, Atish Zaini, Nurmahirah Binte Mohammed Poh, Zhi Sheng Wong, Brandon Han Siang Loh, Xinpeng Ng, Aik Seng Low, Zun Siong Prasannan, Praseetha Gong, Chun Tan, Michelle Guet Khim Nagarajan, Chandramouli Huang, Dachuan Lu, Pang Wan Lim, Jing Quan Barrans, Sharon Ong, Choon Kiat Lim, Soon Thye Chng, Wee Joo Follows, George Hodson, Daniel J Du, Ming Qing Goh, Yeow Tee Tan, Suat Hoon Grigoropoulos, Nicholas Francis Verma, Navin Kumar |
| format |
Article |
| author |
Kizhakeyil, Atish Zaini, Nurmahirah Binte Mohammed Poh, Zhi Sheng Wong, Brandon Han Siang Loh, Xinpeng Ng, Aik Seng Low, Zun Siong Prasannan, Praseetha Gong, Chun Tan, Michelle Guet Khim Nagarajan, Chandramouli Huang, Dachuan Lu, Pang Wan Lim, Jing Quan Barrans, Sharon Ong, Choon Kiat Lim, Soon Thye Chng, Wee Joo Follows, George Hodson, Daniel J Du, Ming Qing Goh, Yeow Tee Tan, Suat Hoon Grigoropoulos, Nicholas Francis Verma, Navin Kumar |
| author_sort |
Kizhakeyil, Atish |
| title |
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_short |
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_full |
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_fullStr |
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_full_unstemmed |
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_sort |
ddx3x loss is an adverse prognostic marker in diffuse large b-cell lymphoma and is associated with chemoresistance in aggressive non-hodgkin lymphoma subtypes |
| publisher |
BMC |
| publishDate |
2022 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/228996 |
| _version_ |
1781793147866578944 |